The Company provides pharmaceutical and pharmacy benefit management services.


Updates from The Motley Fool

Latest updates on BioScrip from Fool.com.
Why BioScrip Inc. Shares Stumbled

BioScrip shares dip despite the company delivering strong revenue growth in the fourth quarter. S...

Infusing a Fragmented Market

Consolidating the home infusion market continues to offer mixed results for investors due to marg...



Stock Performance

View Interactive BIOS Charts
Sponsored by

Key Data Points

Primary metrics and data points about BioScrip.
Current Price: $1.60
Prev Close: $1.62
Open: $1.64
Bid: $1.57
Ask: $1.63
Day's Range: $1.54 - $1.66
52wk Range: $0.98 - $3.43
Volume: 2,571,368
Avg Vol 1,920,119
Market Cap: $188M
P/E (ttm): -2.31
EPS (ttm): ($0.70)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about BioScrip.
CAPS Rating 2 out of 5
 
143 Outperform
19 Underperform
CAPS All Stars
 
18 Outperform
8 Underperform

How do you think BioScrip will perform against the market?



You pick for BioScrip is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Daniel E Greenleaf, CEO

19% Approve

Based on 16 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for BioScrip.

The Company provides pharmaceutical and pharmacy benefit management services.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Retail